The influenza vaccine market size is projected to grow from USD 8.27 billion in 2025 to USD 17.41 billion by 2035, representing a CAGR of 7.72% during the forecast period till 2035. Influenza, also known as flu, an acute respiratory infection spread by the influenza virus is a common viral infectious disease. According to WHO

The medical second opinion market size is projected to grow from USD 7.42 billion in 2025 to USD 29.44 billion by 2035, representing a CAGR of 14.77% during the forecast period till 2035. The distribution of the market for second opinion is divided into health insurance companies, hospitals, physicians, specialty clinics, and others. As per this medical second opinion market report, the hospital segment is expected to drive the market demand with (~41%) of the market share and will likely domina...

The atopic dermatitis market size is projected to grow from USD 13.69 billion in 2025 to USD 31.86 billion by 2035, representing a CAGR of 8.81% during the forecast period till 2035. According to an Oxford Academic report, nearly 2.6% of the population is affected by atopic dermatitis worldwide where children are more affected compared to adults,. This number exhibits a high prevalence of skin conditions similar to eczema that raise the atopic dermatitis market demand. Atopic dermatitis also kno...

The global thermoplastic elastomers market size is valued at USD 26.77 billion in 2024 and is poised to reach USD 47.25 billion by 2035, representing a higher CAGR of 5.30% during the forecast period. In November 2024, GEON Performance Solutions launched a new TPE manufacturing line in Mexico facility, in order to expand the production of thermoplastic elastomers and thermoplastic vulcanizate.

The global myasthenia gravis market is estimated to grow from USD 1.61 billion in 2024 to USD 3.13 billion by 2035, representing a compounded annual growth rate (CAGR) of 6.20% during the forecast period. As per the report of the Myasthenia Gravis Foundation of America, over 70,000 people in US have been diagnosed with myasthenia gravis, indicating a significant increase in the number of patients. It is important to highlight here that since 2017, the USFDA has approved several monoclonal antibo...

Over the last two decades, medical researchers have been able to achieve proof-of-concept and demonstrate the viability of benefits of mRNA-based interventions. In fact, currently, there are more than 65 mRNA-based therapeutics and over 85 mRNA vaccines under development. In vitro transcribed mRNA is now being evaluated as a treatment option for several oncological and genetic disorders. Moreover, experts believe that the applications of this upcoming product class are potentially limitless.

The global 3D printed drugs market size is valued at USD 281.63 million in 2024 and is poised to reach at USD 605.09 million by 2035, representing a CAGR of 7.20% during the forecast period. In September 2024, the APL (Leading manufacturer of extemporaneous medicine) and CurifyLabs (Finnish Health Tech Company) forged a collaboration deal to increase the administration of medicines to children using advanced 3D printing technology. Examples of key players engaged in this domain (which have also...

The global oligonucleotide synthesis market, valued at USD 5.7 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 13.5 billion by 2035, with a 7.9% CAGR during the forecast period 2026 to 2035. In terms of application area, the research and diagnostics segment holds the highest share (~60%) of the market. Based on the type of oligonucleotide synthesized, the antisense oligonucleotide segment holds the largest market share (more than 60%).  With respect to scale of operatio...

The global microbiome manufacturing market size is estimated to grow from USD 40.6 million in 2024 to USD 186.7 million by 2035, representing a CAGR of 14.9% during the forecast period. It is worth highlighting that, in November 2022, the US Food and Drug Administration (FDA) approved the first microbiome-based therapy, RBX2660 (developed by Rebiotix) for the treatment of recurrent Clostridium difficile infection. Notably, in April 2023, SER-109, a microbiome-based first oral therapy developed b...

The cell line characterization and cell line development market, valued at USD 2.71 billion in 2025, is projected to grow to USD 3.14 billion in 2026 and USD 8.38 billion by 2035, representing a CAGR of 11.5% during the forecast period. Cell line development and cell line authentication is a cost-intensive and complex process that requires multidisciplinary expertise. In fact, considering their critical role in drug discovery and development, cell lines need to be appropriately tested and valida...

The global cold chain market for pharmaceuticals, valued at USD 6.6 billion in 2025, is projected to reach USD 6.9 billion in 2026 and USD 9.6 billion by 2035, with a 3.8% CAGR during the forecast period, 2026 to 2035. The pharma cold chain specifically addresses the requirements of freezing / cryogenic holding temperature for a wide variety of temperature sensitive pharmaceutical products, such as biologics, covid vaccines, human organs, and certain conventional pharmacological interventions, s...

The global chronic kidney disease market size is valued at USD 38.91 billion in 2024 and is expected to reach USD 67.36 billion by 2035, representing a CAGR of 5.12% during the forecast period. Chronic kidney disease (CKD) refers to the long-term condition in which a patient gradually loses its kidney function. In most cases, patients suffering from chronic kidney disease remain undiagnosed until the kidney function declined to 75% as its symptoms are rarely observed (which include swollen ankle...

The global retinal biologics market size is currently valued at $ 25.65 billion and is poised to reach $ 57.47 billion by 2035, it is estimated to grow at a CAGR of 7.61%, during the forecast period. There has been a surge in the number of patients suffering from various retinal diseases, such as diabetic retinopathy, glaucomatous retinal degeneration and age-related macular degeneration. As per the World Health Organization, in 2023, nearly 2.2 billion people have near, or distance vision impai...

The global drug delivery technologies market is currently valued at $0.52 billion and is poised to reach $6.42 billion by 2035, at a CAGR of 25.5%, during the forecast period. Given the inherent requirement for frequent medication, patients suffering from such long-lasting clinical conditions generally end up spending high amounts on not only the prescribed therapeutic regimen, but also on numerous hospital visits for dose administration. Since 2018, more than 250 biologics (including antibody d...

The global stem cell manufacturing market for contract manufacturers is estimated to grow from USD 76 million in 2026 to USD 279 million by 2035. It is anticipated to grow at a healthy CAGR of 15.6% during the forecast period. According to the report of the National Institute of Health, in 2024, nearly 2,001,140 new cases of cancer have been diagnosed, and around 611,720 deaths have been projected to occur in the US due to cancer. Further, the report of the Centered for Disease Control and Prev...

The vaccines market size is currently valued at $48 billion and is projected to reach $94 billion by 2030, representing a CAGR of 11.9% during the forecast period till 2030. The above sales exclude COVID-19 sales. The outbreak of infectious diseases worldwide has underscored the requirement of advanced vaccines to prevent the risk of diseases. In June 2024, the World Health Organization released a report on the disease outbreaks indicating the increasing number of individuals affected by Avian i...

The global biomaterials market is currently worth around USD 193 billion and is expected to reach USD 442 billion by 2035. It is expected to grow at a CAGR of 7.9% during the forecast period till 2035. The global market for biomaterials is experiencing significant growth, driven by several key trends including increasing adoption of biocompatible materials in medical devices and implants, with advancements in material science enhancing their performance characteristics. North America is emerging...

Global expenditure on veterinary healthcare has been on the rise, driven by various factors such as increased pet ownership, growing disposable income, and the rising willingness of people to spend on their pets' well-being. The veterinary healthcare industry has experienced substantial growth worldwide. In October 2023, Pirbright and VIDO announced the expansion of their collaboration to advance vaccine manufacturing to drive innovations for animal health. Additionally, in February 2022, Dyadic...

The botox market, valued at USD 5.1 billion in 2025, is projected to grow to USD 5.6 billion in 2026 and USD 13.7 billion by 2035, representing a CAGR of 10.4% during the forecast period. Given the need and rising number for botox treatments with each passing year, botox injection manufacturers are also emerging. Owing to the rising focus on facial aesthetics, growing number of skincare clinics, rising influence from the social media influencers, the botulinum toxin market, which is a significan...

The global intravenous immunoglobulin market, valued at USD 14.4 billion in 2024, is projected to reach USD 15.6 billion in 2025 and USD 32.3 billion by 2035, representing a CAGR of 7.6% during the forecast period. FDA has till now approved at least 12 human IVIg for treatment of several disorders. It is worth highlighting that Yimmugo, developed by Biotest, is the most recent intravenous immunoglobulin to receive approval in the United Kingdom for the treatment of patients with congenital and a...